The FDA approved the first over-the-counter drug, naloxone nasal spray, last year to help reduce drug overdose deaths.
Opioid agonists are the gold standard for the treatment of OUD but have not been able to solve the opioid crisis.
AstraZeneca Fends Off Adcomm’s Safety Concerns on Andexxa, Axes Mid-Stage Opioid Use Disorder Drug
The pharma is seeking full approval for its anticoagulation reversal drug Andexxa, which the FDA granted accelerated approval ...
Opioid overdose deaths have decreased for 12 months, with 70,655 predicted deaths through June 2024, down from 86,401 in June ...
Protonitazene, a synthetic opioid three times stronger than fentanyl, was connected to an overdose in Stevenson Ranch. Dealer ...
A recent study by North Carolina State University exposes a critical shortfall in opioid treatment availability within the ...
Narcan is the only reversal drug distributed free of charge to organizations in state, but it's not the only reversal drug ...
AstraZeneca has ended work on an opioid use disorder (OUD) drug after the orexin 1 receptor antagonist demonstrated a ...
New litigation centered on increasing access to substance-use disorder treatment in jails and prisons is helping to reduce ...
Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...
The FDA has approved an opioid withdrawal therapy from Indivior as part of its drive to combat the addiction epidemic sweeping America. The licence for monthly injected Sublocade (buprenorphine ...
CBS Colorado on MSN6d
Colorado harm reduction agencies look to more opioid overdose reversal drugsNarcan is the only reversal drug distributed free of charge to organizations in state, but it's not the only reversal drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback